At 48 weeks, participants receiving the highest dose combination of 9 mg eloralintide and 15 mg tirzepatide achieved an ...

Pharmacists are moving well beyond the dispensing counter and are taking on active roles in managing patients alongside ...

Viral pathogens are increasingly recognized in up to 26% of adult CAP hospitalizations, with influenza and RSV historically ...

Similarly, a large cross-sectional study in China evaluating individuals who recovered from COVID-19 found that 42.2% exhibited hesitancy toward subsequent doses, with higher levels of pandemic ...

Pharmacy benefit manager (PBM) reform is gaining momentum nationwide, but experts caution that pharmacies, a cornerstone of ...

Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of ...

Throughout October, key recognition dates highlight the profession’s diverse workforce, including National Student ...

Four approved PrEP options now span daily pills and long-acting injections. The faculty review how each agent works and where ...

Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.

At eligible safety-net organizations, the 340B Drug Pricing Program may also support access. However, discounted acquisition costs do not establish a patient’s final charge. Pharmacists should confirm ...

Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.

The necessity of centering equity on community needs is a global phenomenon. A joint study by the Sabin Vaccine Institute and ...